R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma

Roosa Enni Inkeri Prusila, Kirsi-Maria Haapasaari, Katja Marin, Marjukka Pollari, Ylermi Soini, Martine Vornanen, Marja-Liisa Karjalainen-Lindsberg, Taina Turpeenniemi-Hujanen, Outi Kuittinen

Forskningsoutput: TidskriftsbidragBrevVetenskapligPeer review

Originalspråkengelska
TidskriftActa Oncologica
Volym57
Utgåva9
Sidor (från-till)1265-1267
Antal sidor3
ISSN0284-186X
DOI
StatusPublicerad - 2018
MoE-publikationstypA1 Tidskriftsartikel-refererad

Vetenskapsgrenar

  • 3122 Cancersjukdomar

Citera det här

Prusila, R. E. I., Haapasaari, K-M., Marin, K., Pollari, M., Soini, Y., Vornanen, M., ... Kuittinen, O. (2018). R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma. Acta Oncologica, 57(9), 1265-1267. https://doi.org/10.1080/0284186X.2018.1450522
Prusila, Roosa Enni Inkeri ; Haapasaari, Kirsi-Maria ; Marin, Katja ; Pollari, Marjukka ; Soini, Ylermi ; Vornanen, Martine ; Karjalainen-Lindsberg, Marja-Liisa ; Turpeenniemi-Hujanen, Taina ; Kuittinen, Outi. / R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma. I: Acta Oncologica. 2018 ; Vol. 57, Nr. 9. s. 1265-1267.
@article{2727beabda0d4c3497bac9c4231a89a5,
title = "R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma",
keywords = "PHASE-2 TRIAL, RITUXIMAB, DISEASE, MANAGEMENT, THERAPY, 3122 Cancers",
author = "Prusila, {Roosa Enni Inkeri} and Kirsi-Maria Haapasaari and Katja Marin and Marjukka Pollari and Ylermi Soini and Martine Vornanen and Marja-Liisa Karjalainen-Lindsberg and Taina Turpeenniemi-Hujanen and Outi Kuittinen",
year = "2018",
doi = "10.1080/0284186X.2018.1450522",
language = "English",
volume = "57",
pages = "1265--1267",
journal = "Acta Oncologica",
issn = "0284-186X",
publisher = "Taylor & Francis",
number = "9",

}

Prusila, REI, Haapasaari, K-M, Marin, K, Pollari, M, Soini, Y, Vornanen, M, Karjalainen-Lindsberg, M-L, Turpeenniemi-Hujanen, T & Kuittinen, O 2018, 'R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma', Acta Oncologica, vol. 57, nr. 9, s. 1265-1267. https://doi.org/10.1080/0284186X.2018.1450522

R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma. / Prusila, Roosa Enni Inkeri; Haapasaari, Kirsi-Maria; Marin, Katja; Pollari, Marjukka; Soini, Ylermi; Vornanen, Martine; Karjalainen-Lindsberg, Marja-Liisa; Turpeenniemi-Hujanen, Taina; Kuittinen, Outi.

I: Acta Oncologica, Vol. 57, Nr. 9, 2018, s. 1265-1267.

Forskningsoutput: TidskriftsbidragBrevVetenskapligPeer review

TY - JOUR

T1 - R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma

AU - Prusila, Roosa Enni Inkeri

AU - Haapasaari, Kirsi-Maria

AU - Marin, Katja

AU - Pollari, Marjukka

AU - Soini, Ylermi

AU - Vornanen, Martine

AU - Karjalainen-Lindsberg, Marja-Liisa

AU - Turpeenniemi-Hujanen, Taina

AU - Kuittinen, Outi

PY - 2018

Y1 - 2018

KW - PHASE-2 TRIAL

KW - RITUXIMAB

KW - DISEASE

KW - MANAGEMENT

KW - THERAPY

KW - 3122 Cancers

U2 - 10.1080/0284186X.2018.1450522

DO - 10.1080/0284186X.2018.1450522

M3 - Letter

VL - 57

SP - 1265

EP - 1267

JO - Acta Oncologica

JF - Acta Oncologica

SN - 0284-186X

IS - 9

ER -

Prusila REI, Haapasaari K-M, Marin K, Pollari M, Soini Y, Vornanen M et al. R-Bendamustine in the treatment of nodular lymphocyte-predominant Hodgkin lymphoma. Acta Oncologica. 2018;57(9):1265-1267. https://doi.org/10.1080/0284186X.2018.1450522